Fidelity Select Biotechnology Portfolio FBIOX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 28.24  /  −0.25 %
  • Total Assets 6.0B
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 1.47%
  • Turnover 45%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0

Morningstar’s Analysis FBIOX

Will FBIOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Biotechnology holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBIOX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 42.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

11.04 640M
Healthcare

Krystal Biotech Inc

10.61 615M
Healthcare

Amgen Inc

6.79 393M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.31 134M
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

2.19 127M
Healthcare

Insmed Inc

2.11 122M
Healthcare

argenx SE ADR

2.08 121M
Healthcare

Ascendis Pharma AS

2.02 117M
Healthcare

Alnylam Pharmaceuticals Inc

1.81 105M
Healthcare

Jazz Pharmaceuticals PLC

1.75 102M
Healthcare

Sponsor Center